Case report of uterine carcinosarcoma with incisional site recurrence.

Uterine carcinosarcoma (CS), also known as malignant mixed Mullerian tumors, are very aggressive tumors accounting for <4 % of uterine cancers. These uterine cancers have poor survival rates, even when diagnosed at an early stage [1]. Though surgery is the mainstay of treatment, the role of adjuvant chemotherapy and radiotherapy is being extensively studied as the postoperative recurrence rates and metastases are very high [2]. Hence, various single and combinations of chemotherapeutic regimens and radiotherapeutic approaches are being evaluated [3, 4, 5] Here, we present a rare case of CS with incisional site recurrence which was managed effectively by paclitaxel and cisplatin-based chemotherapy.